Series B funding round for Recursion Pharmaceuticals raising $60M in October 2017
Series B funding round for Recursion Pharmaceuticals raising $60M in October 2017
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Jeff Seibert |
| Angel | Dylan Taylor |
| Angel | Chris Boshuizen |
| Angel | Wayne Chang |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$435M
Top Valuation
-
Recursion Pharmaceuticals raised $60M in a Series B round.
The round was announced on 10/01/17.